ALLAN D. MARKS, M.D.; BERTRAM J. CHANNICK, M.D.; E. VICTOR ADLIN, M.D.; REX K. KESSLER, M.D.; LEONARD E. BRAITMAN, Ph.D.; BARRY S. DENENBERG, M.D.
Mitral valve prolapse is more prevalent in patients with autoimmune diffuse toxic goiter, suggesting a possible etiologic association. The prevalence of mitral valve prolapse was determined in 75 patients with chronic lymphocytic thyroiditis, another autoimmune thyroid disorder, and in 50 healthy control subjects. Mitral valve prolapse was found in 31 of 75 (41%) patients with chronic lymphocytic thyroiditis and in 4 of 50 (8%) controls (odds ratio, 8.10; 95% confidence interval, 2.64 to 24.83;p < 0.0005). The age-race adjusted odds ratio was 9.26 (95% confidence interval, 2.83 to 30.26; p < 0.0005). No correlation between the prevalence of mitral valve prolapse and the presence of hypothyroidism, serum antithyroid antibodies, or the duration of chronic lymphocytic thyroiditis was found. The prevalence of mitral valve prolapse is substantially increased in patients with the autoimmune thyroid disorders.
MARKS AD, CHANNICK BJ, ADLIN EV, et al. Chronic Thyroiditis and Mitral Valve Prolapse. Ann Intern Med. 1985;102:479–483. doi: https://doi.org/10.7326/0003-4819-102-4-479
Download citation file:
Published: Ann Intern Med. 1985;102(4):479-483.
Cardiology, Endocrine and Metabolism, Thyroid Disorders, Valvular Heart Disease.
Results provided by:
Copyright © 2020 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use